Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 363,855 |
|
|||||
| News | - | ||||||
| Day High | 21.78 | Low High |
|||||
| Day Low | 19.785 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| AnaptysBio Inc | ANAB | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -1.64 | -7.64% | 19.83 | 15:30:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 21.29 | 19.785 | 21.78 | 19.83 | 21.47 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,605 | 363,855 | US$ 20.84 | US$ 7,581,356 | - | 13.36 - 27.50 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:20:00 | 94 | US$ 19.83 | USD |
AnaptysBio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 530.44M | 26.76M | - | 17.16M | -163.62M | -6.11 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AnaptysBio News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANAB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.81 | 25.62 | 19.785 | 22.77 | 341,768 | -4.98 | -20.07% |
| 1 Month | 24.34 | 25.62 | 19.785 | 21.89 | 395,190 | -4.51 | -18.53% |
| 3 Months | 24.04 | 27.50 | 19.785 | 23.30 | 325,815 | -4.21 | -17.51% |
| 6 Months | 18.85 | 27.50 | 13.36 | 21.10 | 286,080 | 0.98 | 5.20% |
| 1 Year | 22.71 | 27.50 | 13.36 | 20.33 | 259,010 | -2.88 | -12.68% |
| 3 Years | 21.57 | 37.89 | 13.36 | 23.71 | 245,275 | -1.74 | -8.07% |
| 5 Years | 73.48 | 79.09 | 9.16 | 23.66 | 326,986 | -53.65 | -73.01% |
AnaptysBio Description
| AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements. |
